Anticancer Plants: Clinical Trials and Nanotechnology

Volume 3

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Botany
Cover of the book Anticancer Plants: Clinical Trials and Nanotechnology by , Springer Singapore
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9789811082160
Publisher: Springer Singapore Publication: July 3, 2018
Imprint: Springer Language: English
Author:
ISBN: 9789811082160
Publisher: Springer Singapore
Publication: July 3, 2018
Imprint: Springer
Language: English

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer.

Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, *podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine *etc. have been isolated and purified from these medicinal plants.

Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk.

“Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer.

Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, *podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine *etc. have been isolated and purified from these medicinal plants.

Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk.

“Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

More books from Springer Singapore

Cover of the book Hybrid Machine Intelligence for Medical Image Analysis by
Cover of the book New Age Herbals by
Cover of the book Higher Education in the Middle East and North Africa by
Cover of the book Myanmar’s Foreign Exchange Market by
Cover of the book Successful Transposition of Lesson Study by
Cover of the book Towards A Common Future by
Cover of the book Education in Malaysia by
Cover of the book Mobility Engineering by
Cover of the book Anatomy for the Generic Surgical Sciences Examination (GSSE) by
Cover of the book New Media, Knowledge Practices and Multiliteracies by
Cover of the book Pacific Rim Objective Measurement Symposium (PROMS) 2016 Conference Proceedings by
Cover of the book Economic Analysis and Forecast of China (2015) by
Cover of the book Financing without Bank Loans by
Cover of the book China Satellite Navigation Conference (CSNC) 2016 Proceedings: Volume I by
Cover of the book Introduction to Biomolecular Structure and Biophysics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy